By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ark Therapeutics Ltd. 

6 Warren Mews

London    W1T 6AR  United Kingdom
Phone: 44-20-7388-7722 Fax: +44-20-7388-7805



Company News
Laurantis Pharma Oy and Ark Therapeutics Sign Manufacturing Agreement for Production of Lymfactin™ Investigational Treatment for Breast Cancer-Associated Lymphedema 10/15/2012 9:07:15 AM
Ark Therapeutics Led Consortium Wins €5.3 Million EU Framework Program 7 Grant 7/14/2011 9:22:41 AM
Ark Therapeutics Receives €0.6 Million Finnish Grants for Development of Lentiviral Production Platform 7/6/2011 1:26:15 PM
Ark Therapeutics Interim Management Statement 5/17/2011 10:50:40 AM
Ark Therapeutics Preliminary Results for the Year Ended 31 December 2010 3/9/2011 9:30:05 AM
Ark Therapeutics Release: Appointment of CFO, Russell Banks 3/3/2011 11:22:38 AM
Ark Therapeutics Board Changes, Dr David Bloxham Appointed Non-executive Director 2/22/2011 10:50:15 AM
Ark Therapeutics Release: Disposal of the Majority of the Group's Woundcare Business for up to £2.7 Million 2/8/2011 9:11:02 AM
Positive Results Gor Ark Therapeutics Pre-Clinical Product Candidate EG013 in the Treatment of Foetal Growth Restriction 11/29/2010 11:45:50 AM
Ark Therapeutics Restructures, Cuts Headcount and Looks for Partners 9/9/2010 8:15:56 AM